Loading clinical trials...
Loading clinical trials...
Minimal Residual Disease-directed Therapy for Low-risk and Intermediate-risk Acute Myeloid Leukemia.
Conditions
Interventions
MRD-directed therapy
Locations
1
China
Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, China
Start Date
August 1, 2016
Primary Completion Date
August 31, 2019
Completion Date
December 31, 2019
Last Updated
March 4, 2020
NCT06285890
NCT06220162
NCT04065399
NCT06484062
NCT04628026
NCT06994676
Lead Sponsor
Nanfang Hospital, Southern Medical University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions